维普中文期刊产品整合服务
13篇 您的检索式:作者名="LATHA E"
    题名 作者 年代 出处 被引量
1Effect of Crataeva nurvala in experimental urolithiasis 显示文摘Varalakshmi P Shamila Y Latha E 1990J Ethnopharmacol1990,28,3:1
2Clustering of cardio-vascular risk factors in urban Asian Indians显示文摘RAMACHANRAN A SHEHALATHA C LATHA E 1998Diabetes Care1998,21,:1
3Studies on particulate matter (PMI0) and its precursors over urban environment of reading, UK显示文摘Latha K M Highwood E J 2006Journal of Quantitative Spectroscopy and Radiative Transfer2006,101,2:1
4Crystallization and microhardess of calcium oxalate monohydrate显示文摘E K Girija S C Latha S N Kalkura 1998Mater Chem Phys1998,52,3:1
5Studies on particulate matter (PM10) and its precursors over urban environment of Reading,UK显示文摘Latha Madhavi K Highwood E J 2006Journal of Quantitative Spectroscopy and Radioactive Transfer2006,101,2:1
6Young breast cancer in a spe-cialised breast unit in Singapore : clinical, radiological and patholog-ical factors显示文摘Teo SY Chuwa E Latha S 2014Ann Acad Med Singapore2014,43,2:1
7Studies on particulate matter (PM10) and its precursors over urban environment of Reading,UK显示文摘LATHA K M HIGHWOOD E J 2006Journal of Quantitative Spectroscopy & Radiative Transfer2006,101,2:1
8Crystallization and microhardness of calcium oxalate monohydrate显示文摘GIRIJA E K CHRISTIC LATHA S SUBRAMANIAN C 1998Materials Chemistry and Physics1998,52,:1
9Studiesonparticulate matter (PM10) andits precursors over urban environment of reading, UK 显示文摘Latha K M Highwood E J 2006Journal of Quantitative Spectroscopy & Radiative rans- fer2006,101,2:1
10Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease显示文摘AIM To evaluate a calcium activated potassium channel(KCa3.1) inhibitor attenuates liver disease in models of non-alcoholic fatty liver disease(NAFLD).METHODS We have performed a series of in vitro and in vivo studies using the KCa3.1 channel inhibitor, Senicapoc. Efficacy studies of Senicapoc were conducted in toxin-, thioacetamide(TAA) and high fat diet(HFD)-induced models of liver fibrosis in rats. Efficacy and pharmacodynamic effects of Senicapoc was determined through biomarkers of apoptosis, inflammation, steatosis and fibrosis. RESULTS Upregulation of KCa3.1 expression was recorded in TAA-induced and high fat diet-induced liver disease. Treatment with Senicapoc decreased palmitic aciddriven Hep G2 cell death.(P < 0.05 vs control) supporting the finding that Senicapoc reduces lipiddriven apoptosis in Hep G2 cell cultures. In animals fed a HFD for 6 wk, co-treatment with Senicapoc,(1) reduced non-alcoholic fatty liver disease(NAFLD) activity score(NAS)(0-8 scale),(2) decreased steatosis and(3) decreased hepatic lipid content(Oil Red O, P < 0.05 vs vehicle). Randomization of TAA animals and HFD fed animals to Senicapoc was associated with a decrease in liver fibrosis as evidenced by hydroxyproline and Masson's trichrome staining(P < 0.05 vs vehicle). These results demonstrated that Senicapoc mitigates both steatosis and fibrosis in liver fibrosis models.CONCLUSION These data suggest that Senicapoc interrupts more than one node in progressive fatty liver disease by its anti-steatotic and anti-fibrotic activities, serving as a double-edged therapeutic sword.latha paka david e smith dawoon jung siobhan mccormack ping zhou bin duan jing-song li jiaqi shi yong-jie hao kai jiang michael yamin itzhak d goldberg prakash narayan 2017World Journal of Gastroenterology2017,23,23:1
11Multiplex PCR assay for the detection of aflatoxigenic and non-aflatoxigenic Aspergilli 显示文摘Latha R Manonmani H K Rati E R 2008Researvh Journal of Microbiology2008,3,4:1
123D- QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase显示文摘Latha R S Vijayaraj R Singam E R A 2011Chemical Biology & Drug Design2011,78,3:1
13Dependence of single-molecule junction conductance on molecular conformarion显示文摘Latha Venkataraman Jennifer E Klare Colin NuckoUs 2006Nature2006,442,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费